Sansure Biotech's (SHA:688289) mycobacterium tuberculosis DNA fluorescence diagnostic kit received a European Union's In Vitro Diagnostic Regulation or IVDR certificate, the company said in its filing on the Shanghai Stock Exchange.
The IVDR certificate, which is valid until July 24, 2028, is given to an in-vitro diagnostic medical device after it met testing needs of medical institutions at different levels in different countries and regions, according to the Wednesday filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments